002821 Asymchem Laboratories(Tianjin)Co.,Ltd.
Noon Closed 05-07 11:30:00
127.79
+3.11
+2.49%
High131.29Low124.98Vol5.42M
Open124.98D1 Closing124.68Amplitude5.06%
Mkt Cap46.13BTradable Cap40.51BTotal Shares361.00M
T/O699.00MT/O Rate1.71%Tradable Shares317.00M
P/B2.51ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Citigroup's Long Position in H-Shares of Asymchem Laboratories (Tianjin) Decreases to 7.11% on Apr 28 From 9.86% - HKEX
THOMSON REUTERS  ·  05-05 17:32
Citigroup's Long Position in H-Shares of Asymchem Laboratories (Tianjin) Decreases to 7.11% on Apr 28 From 9.86% - HKEX
BRIEF-JPMorgan Chase’s Long Position In H-Shares Of Asymchem Laboratories (Tianjin) Decreases To 7.64% On Apr 28 From 8.18%, HKEX Filing Shows
Reuters  ·  05-04 21:20
BRIEF-JPMorgan Chase’s Long Position In H-Shares Of Asymchem Laboratories (Tianjin) Decreases To 7.64% On Apr 28 From 8.18%, HKEX Filing Shows
JPMorgan Chase’s Long Position in H-Shares of Asymchem Laboratories (Tianjin) Decreases to 7.64% on April 28 From 8.18% - HKEX Filing
THOMSON REUTERS  ·  05-04 17:26
JPMorgan Chase’s Long Position in H-Shares of Asymchem Laboratories (Tianjin) Decreases to 7.64% on April 28 From 8.18% - HKEX Filing
Schroders PLC Reduces Stake in Asymchem by 258,900 Shares at HK$113.53 Each
Deep News  ·  04-30
Schroders PLC Reduces Stake in Asymchem by 258,900 Shares at HK$113.53 Each
Norges Bank Reduces Stake in Asymchem by 184,900 Shares at HK$102.86 Per Share
Stock News  ·  04-29
Norges Bank Reduces Stake in Asymchem by 184,900 Shares at HK$102.86 Per Share
Bocom International Raises Asymchem's Target Price to HK$136.6, Keeps Buy Rating
Stock News  ·  04-29
Bocom International Raises Asymchem's Target Price to HK$136.6, Keeps Buy Rating
Asymchem Laboratories Shareholder Transfers HK$177 Million Stake from Citibank to Morgan Stanley Hong Kong Securities
Stock News  ·  04-29
Asymchem Laboratories Shareholder Transfers HK$177 Million Stake from Citibank to Morgan Stanley Hong Kong Securities
Asymchem Laboratories' Profit Falls 6.8% in Q1; Shares Rise 8%
MT Newswires Live  ·  04-28
Asymchem Laboratories' Profit Falls 6.8% in Q1; Shares Rise 8%
Asymchem Laboratories Surges Over 10% on Strong Q1 Adjusted Net Profit Growth and Emerging Business Revenue Jump
Stock News  ·  04-28
Asymchem Laboratories Surges Over 10% on Strong Q1 Adjusted Net Profit Growth and Emerging Business Revenue Jump
Asymchem Q1 net profit drops 6.82% to RMB 304.32 million; revenue rises 16.91% to RMB 1.8 billion
Reuters  ·  04-27
Asymchem Q1 net profit drops 6.82% to RMB 304.32 million; revenue rises 16.91% to RMB 1.8 billion
BRIEF-Asymchem Laboratories (Tianjin) Q1 Net Profit Down 6.8% Y/Y
Reuters  ·  04-27
BRIEF-Asymchem Laboratories (Tianjin) Q1 Net Profit Down 6.8% Y/Y
Goldman Sachs Maintains Positive Outlook on China's CDMO Sector, Favors WuXi AppTec and Asymchem
Stock News  ·  04-27
Goldman Sachs Maintains Positive Outlook on China's CDMO Sector, Favors WuXi AppTec and Asymchem
Asymchem Shares Surge Over 5% in Late Trading as Major TIDES CDMO Project Launches in Tianjin
Stock News  ·  04-27
Asymchem Shares Surge Over 5% in Late Trading as Major TIDES CDMO Project Launches in Tianjin
Asymchem Shares Surge Nearly 6% Afternoon Following Launch of 2 Billion Yuan Macromolecule Drug CDMO Project in Tianjin
Stock News  ·  04-24
Asymchem Shares Surge Nearly 6% Afternoon Following Launch of 2 Billion Yuan Macromolecule Drug CDMO Project in Tianjin
Asymchem Laboratories Profit Rises 19% in 2025
MT Newswires Live  ·  04-21
Asymchem Laboratories Profit Rises 19% in 2025
Norges Bank Increases Stake in Asymchem Laboratories by 85,300 Shares at HK$98.94 Each
Stock News  ·  04-20
Norges Bank Increases Stake in Asymchem Laboratories by 85,300 Shares at HK$98.94 Each
Asymchem Tianjin publishes 2025 annual report
Reuters  ·  04-20
Asymchem Tianjin publishes 2025 annual report
Asymchem Laboratories held extraordinary general meeting to vote on share repurchase, articles changes
Reuters  ·  04-17
Asymchem Laboratories held extraordinary general meeting to vote on share repurchase, articles changes
Asymchem Laboratories Expands TIDES Production Capacity, Enhancing Drug Service Capabilities
Deep News  ·  04-16
Asymchem Laboratories Expands TIDES Production Capacity, Enhancing Drug Service Capabilities
J.P. Morgan Increases Stake in Asymchem by 95,600 Shares at HK$97.68 Per Share
Deep News  ·  04-14
J.P. Morgan Increases Stake in Asymchem by 95,600 Shares at HK$97.68 Per Share

Introduction

Company Name.
凯莱英医药集团(天津)股份有限公司
Industry:
医药制造业
Listing Date:
2016-11-18
Main Business:
　　凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是小分子CDMO解决方案、新兴业务。凯莱英生物AsymBio偶联药物开发平台成功入围第12届WorldADCAwards“BestADCPlatformTechnology”奖项，印证了凯莱英生物在全球抗体偶联药物CDMO领域的卓越地位。
Issue price:
30.53